Gene · 51185
Papers2,935
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,935
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Heteroaryl Glutarimides and Dihydrouracils as Cereblon Ligand Scaffolds for Molecular Glue Degrader Discovery. | ACS Med Chem Lett | 2024 | 39691515 | PubTator, text mining | PubMed |
| One-Step Regioselective Synthesis of N-1-Substituted Dihydrouracils: A Motif of Growing Popularity in the Targeted Protein Degradation Field. | J Org Chem | 2024 | 39656514 | PubTator, text mining | PubMed |
| Identification of suitable target/E3 ligase pairs for PROTAC development using a rapamycin-induced proximity assay (RiPA). | Elife | 2024 | 39641357 | PubTator, text mining | PubMed |
| Chromatin accessibility: biological functions, molecular mechanisms and therapeutic application. | Signal Transduct Target Ther | 2024 | 39627201 | PubTator, text mining | PubMed |
| Neddylation steers the fate of cellular receptors. | Exp Mol Med | 2024 | 39623094 | PubTator, text mining | PubMed |
| Targeting PRMT5 through PROTAC for the treatment of triple-negative breast cancer. | J Exp Clin Cancer Res | 2024 | 39614393 | PubTator, text mining | PubMed |
| Cell-type specific, inducible and acute degradation of targeted protein in mice by two degron systems. | Nat Commun | 2024 | 39613744 | PubTator, text mining | PubMed |
| Leveraging Dual-Ligase Recruitment to Enhance Protein Degradation via a Heterotrivalent Proteolysis Targeting Chimera. | J Am Chem Soc | 2024 | 39606859 | PubTator, text mining | PubMed |
| Investigating Protein Degradability through Site-Specific Ubiquitin Ligase Recruitment. | bioRxiv | 2024 | 39605659 | PubTator, text mining | PubMed |
| Recent Advances in Peptide Drug Discovery: Novel Strategies and Targeted Protein Degradation. | Pharmaceutics | 2024 | 39598608 | PubTator, text mining | PubMed |
| Development of 2-Aminoadenine-Based Proteolysis-Targeting Chimeras (PROTACs) as Novel Potent Degraders of Monopolar Spindle 1 and Aurora Kinases. | ACS Pharmacol Transl Sci | 2024 | 39539259 | PubTator, text mining | PubMed |
| Characteristic roadmap of linker governs the rational design of PROTACs. | Acta Pharm Sin B | 2024 | 39525578 | PubTator, text mining | PubMed |
| Targeted protein degradation: advances in drug discovery and clinical practice. | Signal Transduct Target Ther | 2024 | 39500878 | PubTator, text mining | PubMed |
| Discovery of CRBN-Dependent WEE1 Molecular Glue Degraders from a Multicomponent Combinatorial Library. | J Am Chem Soc | 2024 | 39499896 | PubTator, text mining | PubMed |
| Cereblon-recruiting proteolysis targeting chimeras (PROTACs) can determine the selective degradation of HDAC1 over HDAC3. | Chem Commun (Camb) | 2024 | 39499531 | PubTator, text mining | PubMed |
| CRBN-PROTACs in Cancer Therapy: From Mechanistic Insights to Clinical Applications. | Chem Biol Drug Des | 2024 | 39496477 | PubTator, text mining | PubMed |
| Cereblon mediates macrophage differentiation and microglial phagocytosis by regulating calpain protease activity. | Biomed Pharmacother | 2024 | 39454366 | PubTator, text mining | PubMed |
| Induced degradation of SNAP-fusion proteins. | RSC Chem Biol | 2024 | 39444693 | PubTator, text mining | PubMed |
| Fragment-based approaches to discover ligands for tumor-specific E3 ligases. | Expert Opin Drug Discov | 2024 | 39420586 | PubTator, text mining | PubMed |
| Structure-Activity Relationship of Potent, Selective, and Orally Bioavailable Molecular Glue Degraders of CK1α. | ACS Med Chem Lett | 2024 | 39411539 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51185/papers?page=18